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A B S T R A C T   
Immunoglobulin G (IgG) glycosylation corresponds well with immune system changes, so it can potentially be 
used as a biomarker for the consequences of chronic stress such as low-grade inflammation and enhanced 
immunosenescence in older animals. Here we present a high-throughput glycoproteomic workflow, including 
IgG enrichment, HILIC glycopeptide purification, and nano-LC-MS analysis of tryptic glycopeptides applied for 
the analysis of rat IgG. A cohort of 80 animals was exposed to seven stressors in a customized chronic stress 
protocol with blood and tissue sampling in three timepoints. Young female rats experienced an increase in 
agalactosylated glycoforms on IgG2a and IgG2c accompanied by a decrease in monogalactosylation. Among old 
females, increased galactosylation was observed in the IgG2b subclass, pointing to an anti-inflammatory activity 
of IgG. Additionally, IgG Fc N-glycosylation patterns in Sprague Dawley rats were analyzed, quantified, and 
reported for the first time. Our findings emphasize age-, sex- and subclass-dependent differences in IgG glyco-
sylation related to chronic stress exposure, confirming the relevance of newly developed methods for further 
research in glycobiology of rodent immune response. 
Significance: In this study, we showed that a high-throughput streamlined methodology based on protein L 96- 
well monolithic plates for efficient rat IgG immunoaffinity enrichment from blood plasma, paired with appro-
priate tryptic glycopeptide preparation, HILIC-SPE enrichment, and nano-LC-MS methods was suitable for quick 
processing of large sample sets. We report a subclass-specific profiling and changes in rat IgG Fc galactosylation 
and adrenal gland immunohistochemistry of male and female animals exposed to a customized chronic stress 
protocol.   
1. Introduction 
Glycosylation is an elaborate form of co- and post-translational 
protein modification indirectly encoded by the genome and greatly 
influenced by environmental factors. Immunoglobulin G (IgG) is the 
most abundant plasma glycoprotein, containing a glycan attached to a 
conserved Asn-297 residue at the fragment crystallizable (Fc) domain of 
both heavy chains. Between 15% and 20% of IgG molecules are also 
glycosylated at the fragment antigen-binding (Fab) domain [1]. Minor 
alterations in IgG glycan composition significantly affect IgG effector 
functions, disturbing the pro- and anti-inflammatory equilibrium [1–4]. 
The structural complexity of glycans and their biological functions have 
only begun to unravel since the advent of high-throughput glyco-
analytics. Rats are the animal model of choice for cancer, diabetes, 
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cardiovascular disease, drug discovery and behavioral studies since rat 
pathophysiology represents human pathophysiology much more closely 
than mice pathophysiology does [5]. So far, relevant advances in murine 
glycobiology have covered glycoprofiling of mouse serum [6], and IgG 
glycome and glycoproteome [7–9], revealing extensive sex-, age- and 
strain-specific differences. However, rat glycoscapes have been rarely 
investigated. Comprehensive glycomics already confirmed that the rat 
serum glycan profile was more similar to the human glycan profile than 
was the mouse profile. The rat serum glycan profile shows an unusually 
high diversity of structures, including N-glycans with O-acetylated N- 
acetyl- (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc), typically not 
present in human and mouse sera [10]. A single study on rat IgG glycans 
using MALDI-TOF-MS reported relative proportions of N-linked glycans 
and confirmed the presence of both Neu5Ac and Neu5Gc but did not 
structurally characterize them any further [11]. Rats have four IgG 
subclasses (IgG1, IgG2a, IgG2b and IgG2c) [12], with unknown 
subclass-specific glycosylation variability. IgG1 and IgG2a subclasses 
are considered essential for the chronic infection onset, while IgG2b and 
IgG2c participate in the protection against infection [13]. Although IgG 
glycans are essential in the modulation of immune system function, data 
on rat immunoglobulins glycosylation are scarce. This encouraged us to 
test the hypothesis that IgG glycosylation patterns were interconnected 
with chronic stress [14]. 
N-linked glycosylation plays a vital role in endoplasmic reticulum 
stress coping response, priming cellular defense against apoptosis [15]. 
To the best of our knowledge, IgG N-glycans have never been studied in 
diseases presenting as hyperresponsive or insufficient system-level stress 
response. However, a number of changes in glycoproteins and lectins 
have been described in conditions associated with chronic mental, 
physical, or combined stress [16]. Chronic stress is associated with 
premature senescence and induces maladaptive responses in virtually all 
organ systems [17–21]. It dysregulates the neuroendocrine system and 
results in chronic inflammation, contributing to early thrombotic com-
plications of atherosclerosis and insulin resistance leading to diabetes 
[22–24]. Stressors disturb homeostasis by activating the hypothalamic- 
pituitary-adrenal (HPA) axis and the autonomic nervous system (ANS), 
but also by changing the glycome [25,26]. A recent study identified 
three potential N-glycan biomarkers that could predict stress suscepti-
bility in a rat post-traumatic stress disorder model [27]. The stress 
response significantly depends on age and sex, which is reflected in 
different circulating glucocorticoid (GC) levels and alterations in 
glucocorticoid receptor (GR) signaling after chronic stress exposure 
[28–30]. The various effects of glucocorticoids are modulated by the 
density and activity of GRs, but also by corticosterone synthesis from 11- 
deoxycorticosterone, which is performed by 11β-hydroxylase 
(CYP11B1), and by intracellular interconversion of active corticosterone 
into inactive 11-dehydrocorticosterone, controlled by 11β-hydroxyste-
roid dehydrogenase (HSD11B) [31]. Animal models of chronic stress 
should demonstrate behavioral changes caused by alterations in specific 
brain regions, and indicate activation of low-grade inflammatory pro-
cesses as well as overall alterations of the HPA axis [27,28,30]. 
We aimed to determine the effects of chronic stress on rat IgG Fc- 
specific N-glycosylation patterns by establishing and validating a high- 
throughput glycoproteomic workflow that allows for quick processing 
of large-sample cohorts. This study for the first time reported a site- 
specific N-glycosylation diversity of rat IgG. Additionally, immunohis-
tochemistry of rat adrenal glands was performed to demonstrate the 
HPA axis activation as a biological effect of the chronic stress protocol. 
2. Materials and methods 
2.1. Animals and chronic stress protocol 
The chronic stress protocol was performed from May until December 
2016. Sprague Dawley CR rats (Charles River, Wilmington, MA, USA) 
were assigned to eight groups, with 10 animals in each. Four 
experimental groups were created based on age and sex – young (3.5 
months old) males and females and old (12 months old) males and fe-
males, with matching sham control groups. The protocol strictly adhered 
to the EU directive on laboratory animal welfare and ARRIVE guidelines. 
Pain was monitored twice a day with an adjusted rat grimace scale [32]. 
The chronic stress protocol (Suppl. File 1) was performed through three 
10-day stress cycles, using seven different stressors, with a 14-day re-
covery period between each stress cycle. The complete protocol lasted 
for 10 weeks (Fig. 1). After the third stress cycle had ended, the animals 
were given 14 days to recover from the effects of acute stress. This 
enabled us to identify only the consequences of long-lasting chronic 
stress. The control group was subjected to sham stress – no stressors were 
applied but the animals were handled in the same fashion and in the 
same surroundings as the experimental animals, thereby equilibrating 
the stress caused by handling and surroundings in both groups. After the 
final recovery period, the animals were sacrificed, and tissue samples 
and plasma were obtained. 
2.2. Rat adrenal glands 
Adrenal glands were extirpated from the male and female rats during 
tissue collection at the ages of 6 and 14.5 months, fixed in 10% form-
aldehyde solution, and embedded in paraffin. The tissues were cut into 
6-μm sections with a microtome (SM2000R, Leica). 
2.3. Antibodies 
Highly specific rabbit polyclonal primary antibody to CYP11B1 
(Biorbyt, Cambridge, UK, cat. no: orb5937) and mouse monoclonal 
antibody to glucocorticoid receptor (GR), specifically the membrane 
receptor (kindly provided by prof. Peter Balogh, School of Medicine, 
University of Pècs, Hungary), were used. Secondary donkey-anti-rabbit 
CY3 (Jackson Immunoresearch, West Grove, PA, USA, cat.no: 711-165- 
152) and donkey-anti-mouse CY2 antibodies (Jackson Immunoresearch, 
West Grove, PA, USA, cat.no: 715-175-150) were appropriately com-
bined with the primary antibodies. 
2.4. Single immunofluorescence analysis 
The slides were thoroughly de-paraffinized and immersed into cit-
rate buffer (pH 6) in a steamer (96 ◦C) for 30 min. Nonspecific staining 
was blocked with 5% donkey serum, 5% goat serum and 1% BSA in PBS 
buffer (pH 7.4) for 1 h at room temperature. The slides were then 
incubated in antibody solution, diluted to 1:20 in the case of CYP11B1 
and 1:3000 in the case of GR antibody, overnight in blocking solution at 
+4 ◦C. In the next step, the samples were washed in PBS buffer, incu-
bated in the dark for 4 h at +4 ◦C with appropriate secondary antibodies 
diluted to 1:500. After washing in PBS, coverslips were mounted using 
Vector Laboratories Vectashield® mounting media with DAPI (Vector 
Labs, Burlingame, CA, USA). 
2.5. Immunohistochemical evaluation of immunofluorescence 
At least 5 biological replicates were used for microscopy with the 
Olympus Fluoview FV1000 confocal microscope. The images were ob-
tained with Olympus FV10-ASW 4.2 Viewer software. CYP and GR 
expression in the fascicular layer of the adrenal glands was quantified in 
at least seven representative images, 512 pixels in size. All images were 
analyzed in the Fiji software by measuring the integrated density value 
according to the protocol [33]. 
2.6. Blood plasma sampling and sample randomization 
Rat plasma was collected at three time points: at the beginning of the 
study, one day before the stress protocol started (BASE), at the end of the 
3rd chronic stress cycle (END) and after sacrifice (SAC), and stored at 
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− 20 ◦C. Prior to IgG enrichment, the samples were thawed at +4 ◦C, 
vortexed and centrifuged at 1620 ×g for 10 min. One hundred micro-
liters of each sample was transferred to a corresponding well of a 96-well 
2-mL collection plate (Waters, Milford, MA, USA) predetermined by 
randomization. The sample list was randomized using Microsoft Excel 
2010 software (Microsoft Corp., Redmond, WA, USA). Each of the three 
plates contained additional eight blanks and five standards (100 μL 
each) made from the pooled rat plasma of the same strain. 
2.7. High-throughput protein L immunoaffinity rat IgG enrichment 
IgG from rat plasma was enriched using newly developed 96-well 
plates (Suppl. Fig. 5) with recombinant protein L immobilized to 
monolithic supports (BIA Separations Ltd., Ajdovščina, Slovenia). First, 
the samples were diluted with 1× PBS (pH 7.4) and vacuum-filtered 
through 0.45 μm 96-well Acroprep® filter plate (Pall Corp., NY, USA) 
into a clean 96-well 2-mL collection plate (Waters, Milford, MA, USA). 
The filtered samples were applied to preconditioned monoliths. The 
unbound portion was washed away with 1× PBS, and IgG was eluted 
with 0.1 M formic acid (Merck KgaA, Darmstadt, Germany) and 
immediately neutralized with 1.0 M ammonium bicarbonate (Acros 
Organics, Geel, Belgium). IgG concentration was measured with Nano-
Drop™ 8000 spectrophotometer (Thermo Scientific, Waltham, MA, 
USA) at 280 nm using a built-in program for IgG quantification. Protein 
L monolithic plate was regenerated with 0.1 M formic acid, 10× PBS 
(pH 7.4), 1× PBS, and stored in 20% ethanol (v/v) (Honeywell, Seelze, 
Germany) containing 20 mM TRIS (Sigma-Aldrich, St. Louis, MO, USA) 
and 0.1 M NaCl (Gram-mol Ltd. Zagreb, Croatia), pH 7.4. The eluate was 
frozen at − 20 ◦C until further use. The entire protocol was performed on 
a vacuum manifold (Pall Corp., NY, USA), and a detailed procedure is 
described in Suppl. File 2. 
2.8. Tryptic glycopeptides preparation 
One hundred and fifty microliters of IgG eluate, corresponding to 
~40 μg of protein, was transferred to a 1-mL round-bottom 96-well 
collection plate (Waters, Milford, MA, USA), dried down in vacuo at 
37 ◦C and redissolved in 40 μL 25 mM ammonium bicarbonate (Sigma- 
Aldrich). For digestion, sequencing grade trypsin (Promega Corp., 
Madison, WI, USA) at 1:20 protease:protein ratio (w/w) was added, and 
the samples were incubated for 18 h at 37 ◦C in a foil-sealed plate. 
2.9. High-throughput HILIC glycopeptide enrichment 
Glycopeptide enrichment following trypsin digestion was performed 
with Chromabond® HILIC silica beads (Macherey-Nagel GmbH & Co., 
Düren, Germany) with zwitterionic modification. A 50 mg/mL suspen-
sion of HILIC beads was first prepared in 0.1% (v/v) TFA (Sigma- 
Aldrich) on a magnetic stirrer, and 100 μL of suspension was added to 
each well of the Orochem OF1100 filter plate (Orochem Technologies 
Inc., Naperville, IL, USA). Beads were washed twice with 0.1% TFA (v/v) 
and thrice with 0.1% TFA in 90% ACN (v/v) (Honeywell). The samples 
were brought to 90% ACN final concentration with 0.1% TFA in ACN, 
applied to the preconditioned beads, and unbound analytes were 
washed away with two portions of 0.1% TFA in 90% ACN. 
Glycopeptides were eluted with 0.1% TFA into a clean skirted PCR plate 
by low-speed centrifugation. The eluates were dried in a vacuum 
centrifuge and stored at − 20 ◦C until analysis. For complete protocol, 
refer to Suppl. File 2. 
2.10. Nano-LC-ESI-QqTOF analysis of glycopeptides 
Glycoproteomic analysis was performed with ACQUITY UPLC M- 
class nano-LC system (Waters, Milford, MA, USA) coupled to Compact™ 
QqTOF mass spectrometer via CaptiveSpray™ ESI interface supported 
with nanoBooster™ dopant addition technology (Bruker Daltonik 
GmbH, Bremen, Germany). Dried glycopeptides were redissolved in 40 
μL ultrapure water and 15 μL was injected onto C18 Acclaim™ PepMap™ 
trap column (5 × 0.3 mm, 5 μm, 100 Å, Thermo-Scientific), desalted for 
5 min with a 40 μL/min flowrate of 0.1% TFA (v/v) from the auxiliary 
pump and diverted to an analytical column. The separation was per-
formed on the HALO C18 column (150 × 0.1 mm, 2.7 μm, Advanced 
Materials Technology, Inc., Wilmington, USA) heated to 30 ◦C. Before 
and after each sample was loaded, the trap column was washed by 
injecting 20 μL of i-PrOH/ACN (25:75, v/v) followed by the same vol-
ume of 95% ACN (v/v). A linear 15-min gradient, at a 1 μL/min flowrate, 
starting from 0% eluent B (0.1% TFA in 80% ACN, v/v) and 100% eluent 
A (0.1% TFA, v/v) and finishing at 35% eluent B, was employed for 
efficient separation of rat IgG glycopeptides. After separation, the col-
umn was equilibrated with 100% eluent A for 4 min. 
The mass spectrometer was operated in a reflectron positive ion 
mode with profile spectra acquisition rate at 2 × 0.5 Hz and in m/z range 
600–3000. ACN-doped nebulizing nitrogen gas was provided at 0.2 bar. 
Drying gas heated to 150 ◦C was introduced at 4 L/min, and capillary 
voltage was set to 1.5 kV. Ion transfer time was stepped up from 70 to 
150 μs, and pre-pulse storage time was set to 10 μs. Nano-LC-MS system 
was operated under otofControl, MassLynx and Compass HyStar soft-
ware (all v.4.1). 
This method was also used for MS/MS structural characterization of 
the most abundant IgG glycopeptides from all three subclasses. The 
method modifications and spectra annotation are described in the Suppl. 
File 6. For manual interpretation of fragmentation spectra, Compass 
DataAnalysis (v.4.1) and GlycoWorkbench 2.0 software [34] were 
employed. Glycan structures were depicted using the symbols and rules 
proposed by the Consortium for Functional Glycomics. 
2.11. Method validation 
The workflow was validated for intra-day (repeatability) and inter- 
day (within-laboratory reproducibility) precision for the same glyco-
forms quantified from the cohort samples. The experimental design is 
presented in the Suppl. File 5. 
2.12. Protein L eluate proteomic analysis 
To confirm the presence of rat IgG subclasses and other potentially 
co-enriched proteins in the protein L eluate, we performed a simple 
peptide mapping for protein identification. The details on sample 
preparation, analysis, and database search are given in the Suppl. File 7. 
Fig. 1. Chronic stress protocol scheme. Young and old Sprague Dawley CR rats were assigned to groups based on sex. The experimental group was exposed to a 
customized chronic stress protocol (see Section 2.1 and Suppl. File 1 for details), and the control group was exposed to sham stress. 
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2.13. Glycoproteomic data extraction and pre-processing 
Putative rat IgG glycopeptide compositions were assigned from 
extracted ion chromatograms based on theoretical m/z values calculated 
for doubly, triply and quadruply charged protonated ions. A list of ex-
pected glycoforms for each IgG subclass was prepared based on litera-
ture data on glycan structures comprising murine IgG and plasma 
glycome (Suppl. File 3). Three chromatographic peak clusters were 
defined, and the LaCy Tools data processing package (v.1.0.1, b.5) was 
used for fast automatic peak integration. A detailed description of this 
software and its use has been previously published [35,36]. Original 
data files were first converted to mzXML open data format by Proteo-
Wizard msConvert [37], and chromatograms were aligned based on the 
retention times of three calibrants, i.e., the most abundant glycopeptide 
signals in each cluster. Summed spectra were integrated to cover 95% of 
the theoretical isotopic pattern. The data were manually curated to 
exclude the analytes with an S/N ratio below 9, isotopic pattern quality 
(deviation from theoretical isotopic pattern) above 35%, and mass de-
viation higher than 35 ppm. Only the charge states compliant with these 
three criteria were summed and quantified. Finally, absolute areas were 
normalized to the total area for each of the three IgG subclasses. 
2.14. Statistical analyses 
2.14.1. Immunostaining 
Statistical analysis of immunostaining data was performed with 
Statistica 12 software (TIBCO, Palo Alto, CA, USA). A p-value of <0.05 
was considered significant. The interaction between stress exposure, 
age, sex and CYP and GR expression was analyzed with a three-way 
factorial ANOVA. 
2.14.2. Glycoproteomic data analysis 
In order to minimize experimental variation from the measurements, 
LC-MS glycopeptide data were normalized and batch corrected. To make 
measurements across samples comparable, normalization by total area 
was performed. Before batch correction, normalized glycan measure-
ments were log-transformed due to the right-skewness of their distri-
butions and the multiplicative nature of batch effects. The batch 
correction was performed on log-transformed measurements with the 
ComBat method (R package sva), where the technical source of variation 
(which sample was analyzed on which plate) was modeled as batch 
covariate. To correct the measurements for experimental noise, esti-
mated batch effects were subtracted from log-transformed measure-
ments. Longitudinal analysis of samples through their observation 
period was performed by implementing a linear mixed-effects model 
(LMM), where time was modeled as a fixed effect while individual ID 
was modeled as a random effect. The effects were estimated using the 
LMM approach, where an effect is defined as the difference between two 
slopes – the first slope represents a change of glycopeptide abundance 
through time in the control group, while the second slope represents a 
change through time in the stress group. Before the analyses, glycan 
variables were transformed to a standard normal distribution by the 
inverse transformation of ranks to normality (R package “GenABEL”, 
function rntransform). Using rank-transformed variables makes the 
estimated effects of different glycopeptides comparable as these will 
have the same standardized variance. False discovery rate (FDR) was 
controlled by the Benjamini-Hochberg procedure at a specified level of 
0.05. The p-values were corrected for multiple testing. The data was 
analyzed and visualized using the R programming language (version 
3.5.2). 
3. Results and discussion 
3.1. Glycoproteomic workflow and rat IgG-Fc glycoform diversity 
Glycoproteomic analyses offer an in-depth overview of IgG subclass 
N-glycoform diversity and are superior to released glycan profiling since 
the latter lacks glycosylation site specificity [38]. Antibody-mediated 
immune response and FcγR binding affinities do not depend only on 
the isotype and subclass but are also heavily affected by Fc-glycosylation 
[39,40]. Therefore, Fc-glycosylation can be a suitable glycobiomarker 
candidate, both in human and rodent clinical trials. 
Affinity capture and purification of most antibody classes from the 
sera of different species, including rats, is made possible by a unique 
interaction of five peptostreptococcal protein L (PpL) immunoglobulin 
(Ig)-binding domains with human Ig kappa, but not lambda, light chains 
(subtypes VκI, VκIII and VκIV). As more than 90% of rat Igs carry kappa 
light chain, all four rat IgG subclasses bind strongly to PpL [41,42], 
offering the possibility for immunoaffinity enrichment for a subsequent 
subclass-specific glycopeptide analysis. 
High-throughput enrichment of rat IgG tryptic glycopeptides was 
performed using zwitterionic Chromabond® HILIC stationary phase to 
ensure optimal capture efficiency for neutral and sialylated glycopep-
tides when combined with TFA as an ion-pairing reagent [43,44]. We 
translated and upscaled this enrichment strategy to a 96-well filter plate 
packed with HILIC beads slurry to perform the clean-up step for three 
plates in a single working day. Although the IgG1 subclass was present in 
the protein L eluate (see Suppl. File 7 for the results of peptide mapping 
experiment), we did not observe its very large (over 5 kDa) tryptic 
glycopeptides, even with longer separation LC gradients or different 
glycopeptide enrichment modes (data not shown). Further subclass- 
specific glycosylation analysis was then made on rat IgG2a, IgG2b and 
IgG2c. 
After fast 15-min nano-LC separation (Fig. 2A; Suppl. Figs. 3 and 4), 
spectra processing and integration, four, nine and three glycoforms for 
IgG2a, IgG2b and IgG2c (Fig. 3), respectively, met the criteria for 
manual data curation (see Section 2.13). Other glycoforms were either 
undetected or below the quantification limit (Fig. 2B, Suppl. Fig. 2). All 
three rat IgG subclasses featured exclusively core-fucosylated mono- and 
biantennary structures. An umbrella feature in each subclass were 
abundant glycoforms FA1, FA2 and FA2G1. Their peptide and glycan 
sequences were further confirmed with MS/MS. We also detected afu-
cosylated, oligomannose and disialylated glycoforms but did not quan-
tify them. Terminally α1,3-galactosylated glycans were not detected, 
leading us to the conclusion that these glycans might not be Fc-linked in 
rat IgG or that their proportion was below the detection limit. Addi-
tionally, the only bisected structure observed on IgG2a was FA2B. IgG2c 
showed the least diversity, with only three glycoforms quantified, 
arguably because the concentration of this subclass in serum is generally 
low [45,46] and many glycopeptides were not detected rather than not 
being present (Suppl. Fig. 2). The same glycoforms were confirmed 
previously in a functionally homologous mouse IgG3 [8,47]. The IgG2b 
levels in normal rat serum are highest among other Ig isotypes [48], and 
this was mirrored in the highest number of glycoforms that we reliably 
quantified, including two digalactosylated (FA2BG2, FA2G2) and three 
monosialylated (FA2BG1Z1, FA2G1Z1, FA2G2Z1) structures (Fig. 3). 
This subclass shares sequence homology and Fc-linked N-glycan di-
versity with mouse IgG2a and IgG2b [8,48]. A single different glyco-
pattern for rat IgG2b was the presence of bisected glycan FA2BG2. 
To assess the technical variation of our glycoproteomic sample 
preparation workflow, we assessed the intra- and inter-day precision for 
the glycoforms quantified in cohort samples and obtained the co-
efficients of variation (CV) below 12% for both parameters and for all 
quantified glycopeptides. Increased variation was observed for the least 
abundant bisected and sialylated glycoforms (Suppl. File. 5). Zaytseva 
et al. [9] made a similar observation when analyzing mouse IgG gly-
copeptides. Higher CVs of bisected glycoforms could also be explained 
by the shielding effect of antennary monosaccharide residues, which 
preclude consistent interaction of bisecting GlcNAc with the HILIC sta-
tionary phase during enrichment [48]. 
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3.2. Chronic stress induces subclass-specific changes in rat IgG 
glycosylation 
Heat shock proteins, acute-phase proteins, lipid peroxidation, 
malondialdehyde (MDA), cortisol level and various biofluid metabolites 
have been proposed as valuable biomarkers of stress-related conditions 
and diseases [49], yet stress-related changes in protein glycosylation 
remain largely unaddressed. Rodents have already been proven a useful 
animal model of chronic stress. Gokul et al. [50] found increased serum 
glutamic-oxaloacetic transaminase, pyruvic transaminase, MDA, corti-
costerone and total antioxidant level in Wistar rats exposed to chronic 
unpredictable mild stress (CUMS) that developed comorbid depression 
accompanied by an inflammatory response. A different, glycomics- 
centered study of CUMS in BALB/c mice revealed altered N-glycan 
patterns of serum glycome [51]. Specifically, a potential biomarker of 
CUMS-induced depression was reported to be the disialylated glycans 
(A2G2S2 and A2G2Z2) ratio, signalizing changes in sialic acids 
expression. These discoveries indicate that protein post-translational 
modifications are affected by chronic stress, allowing the possibility 
that stress triggers changes in rat IgG glycosylation. 
In our study, chronic stress affected rat IgG Fc-linked glycosylation 
only in IgG2a and IgG2c for young females and in IgG2b for old females 
(Fig. 4, Table 1, Suppl. File 4). The most notable glycofeature 
differentiating between control and stress groups was altered gal-
actosylation. IgG2a exhibited an increased level of agalactosylated 
biantennary glycoform FA2, while monogalactosylated FA2G1 showed a 
strong negative group effect. Monoantennary glycoform FA1 was also in 
decline, probably because it is a substrate to which a second GlcNAc 
residue on a Man α1,6 arm of the glycan tri-mannosyl core is attached, 
yielding FA2. A similar situation was observed on IgG2c, where FA1 
decrease was the only significant quantified change. Although a higher 
expected level of biantennary FA2 was not found to exhibit any signif-
icant group effect for this subclass, we cannot exclude its importance 
because it represents a logical step in the N-glycan processing pathway 
leading to a synthesis of core-fucosylated and galactosylated glycan 
structures. A positive group effect for IgG2b FA2G2 digalactosylated 
glycoform was the only quantified glycofeature in old female rats, 
emphasizing contrasts in IgG subclass-specific glycosylation. 
In healthy humans, IgG galactosylation depends on age, with high 
inter-population variability; the relative number of agalactosylated 
structures declines slowly, reaching a minimum at around 25 years of 
age and then increases again [14,52]. In acute systemic inflammation, 
rapid changes in IgG galactosylation resembling “on-and-off mode” were 
described [14,53]. Low total IgG galactosylation was traditionally 
believed to indicate a pro-inflammatory state [54,55], although it is now 
known that not only pathogenic but also bulk endogenous antibody 
Fig. 2. Chromatographic separation of rat IgG-Fc glycoforms for high-throughput glycoprofiling. (A) Representative base peak chromatogram of rat IgG glyco-
peptides forming three peak clusters for each subclass upon reversed-phase nano-LC separation in a fast 15-min gradient. (B) Representative summed mass spectrum 
(4.3–5.1 min) of rat IgG2a peak cluster with annotated doubly, [M + 2H]2+, or triply, [M + 3H]3+, charged glycopeptide ions. For corresponding summed spectra of 
rat IgG2b and IgG2c glycopeptide peak clusters, refer to Suppl. Fig. 2. 
Fig. 3. Relative site-specific abundances of rat IgG2a (A), IgG2b (B) and IgG2c (C) glycoforms in the analyzed chronic stress cohort samples. Boxes represent the 
interquartile range between 25th and 75th percentile, median (solid line) and mean (cross) values. Whiskers represent the minimum and maximum values. Tryptic 
peptide sequences with an N-glycosylation site marked in red are given below each panel. 
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galactosylation levels affect binding to FcγRs and C1q, which disputes 
the previous oversimplified concepts. Studies where the opposite was 
found to be true [56–58] verify that antibody galactosylation effect on 
complement activation is not as straightforward as previously believed. 
In our chronic stress protocol, young females generally exhibited a low- 
galactose IgG glycosylation pattern, which points to a potentially 
increased immune response. In addition, at the end of the study young 
animals were 6 months old, which translates to adolescence in humans 
(15–20 years) [59], characterized by a relatively high agalactosylated 
glycan profile [14,48]. Therefore, an alternative interpretation would be 
that chronic stress relatively delays the maturation of the IgG glycome in 
female animals. 
IgG galactosylation is also affected by estrogens and other sex hor-
mones. Menopausal increase in agalactosylation, reflected primarily 
through high FA2 levels [60], confirms the existence of a hormonal 
route of IgG glycosylation and immune response modulation. This 
possibly explains why galactosylation changes we observed were pro-
nounced in female rats only. Reproductive senescence of female Sprague 
Dawley rats starts at 8–10 months of age and is characterized by a 
decreased number of developing follicles and changes in estrous cyclcity 
[59,61,62]. Thus, the group of old females (12 months) used in our study 
resembles the state of premenopause. Interestingly, chronically stressed 
animals had a higher level of FA2G2 compared with the control group. 
Since in all three subclasses sialylation differences between stressed and 
control groups were not significant, we can only speculate that this in-
crease in FA2G2 level on IgG2b was to be followed by an increase in anti- 
inflammatory sialylated glycoforms, but without conclusive confirma-
tion. This might explain why mature females responded to stress 
differently and experienced a consequent overall increase in IgG2b 
galactosylation, suggesting an anti-inflammatory response. 
While IgG glycosylation in young rats points to a pro-inflammatory 
pattern, indicating probable IgG glycan profile immaturity, older pre-
menopausal rats showed an anti-inflammatory pattern as well, charac-
teristic for a younger and reproductively capable organism still 
protected by sufficient sex hormone levels. In this group we expected an 
increase in agalactosylated glycoforms characteristic for human meno-
pause. Therefore, to properly translate the rat chronic stress model to the 
human system in terms of age, future studies should be performed on 
older animals. 
Specific stressors can also induce different levels of response in males 
and females, which might explain the observed sex-related differences 
[63]. Furthermore, aged rodents might have an impaired stress 
Fig. 4. Chronic stress-related differences in five glycoforms between control and stress groups of female rats across three timepoints. Plasma sampling: BASE = one 
day before protocol start, END = end of 3rd stress cycle, SAC = after sacrificing. Relative abundances and standard deviations for all the glycoforms quantified are 
listed in the Suppl. File 5. 
Table 1 
Five IgG glycoforms had significant positive or negative group effects estimated using the LMM approach in female chronically stressed rats. Standard error (SE) – 
estimated standard deviation of the sampling distribution of the estimated effect. For glycan symbol nomenclature, refer to Fig. 2B.  
IgG subclass Glycoform Depiction Age Sex Group effect Group SE p-value Adjusted p-value 
IgG2a FA1 Young Female − 1.301 0.377 3.54E-03 4.90E-02 
IgG2a FA2 Young Female 2.006 0.497 7.49E-04 1.70E-02 
IgG2a FA2G1 Young Female − 2.318 0.509 5.08E-05 3.45E-03 
IgG2b FA2G2 Old Female 1.861 0.504 6.14E-04 1.70E-02 
IgG2c FA1 Young Female − 2.021 0.573 3.60E-03 4.90E-02  
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perception because of sensorial loss [64], and the effect of some stressors 
is likely to be diminished. 
3.3. Hypothalamic-pituitary-adrenal (HPA) axis activation 
Glycosylation has all the necessary characteristics of an efficient 
stress response system – glycans can be modified extensively and quickly 
in a non-template-driven mode. The importance of glycosylation in 
stress response is visible in the fact that chronic stress affects lymphocyte 
frequency and spleen morphology, evident as an expansion of the red 
pulp compartment and involution of the white pulp, with a loss of the 
prominent marginal zone. Specifically, chronic stress increases mouse T 
lymphocyte frequency, reduces B lymphocyte frequency, and increases 
B-lymphocyte irregularity in the spleen [65,66]. However, the role of 
spleen B lymphocytes in the systemic immune response remains 
unknown. 
The chronic stress protocol (Suppl. File 1) in our study was evaluated 
at the level of the adrenal gland in both sexes and two age groups. For 
this purpose, expressions of CYP11B1 and GR in the fascicular layer of 
the adrenal gland were quantified by immunofluorescence (Suppl. 
Fig. 1). A three-way factorial ANOVA revealed that the interaction of 
three independent variables (age, sex and chronic stress exposure) 
contributed significantly (F(1,54) = 7.881, p < 0.007) to CYP expression 
(Fig. 5), as well as the interactions of stress and age (F(1,54) = 73.118, p 
< 0.001) and age and sex (F(1,54) = 130.391, p < 0.001). Age (F(1,54) =
133.397, p < 0.001), sex (F(1,54) = 14.616, p < 0.001) and chronic stress 
exposure (F(1,54) = 41.249, p < 0.001) also showed statistically signifi-
cant main effects. 
Three-way factorial ANOVA for GR expression in the adrenal gland 
(Fig. 5) yielded a significant interaction between stress and age (F(1,54) 
= 92.058, p < 0.001) and between age and sex (F(1,54) = 140.916, p <
0.001). We also observed significant main effects of stress (F(1,54) =
11.021, p = 0.002) and age (F(1,54) = 296.485, p < 0.001). These results 
indicate that the chronic stress protocol activated the HPA axis, with 
age-specific and sex-specific patterns. 
Chronically stressed young animals of both sexes had similar or 
lower levels of CYP11B1 and GR expression, while old animals had a 
higher expression of both proteins. Typically, chronic stress exposure 
increases glucocorticoid levels and should down-regulate CYP11B1 and 
GR [5,6,67]. In our study, the stress protocol ended with a two-week 
recovery phase. During that time, stress response in young rats 
decreased, resulting in a lower expression of both proteins – a good sign 
of self-limiting stress response. In older rats, on the other hand, a high 
stress response was maintained, which is a maladaptive strategy, 
possibly inducing low-grade inflammation. 
We also observed a higher CYP11B1 and GR expression in young 
females in comparison with young males. Old females, in comparison 
with old males, showed a trend towards lower expression levels of both 
proteins. These findings indicate a sex-specific difference in stress 
response, which may be mediated by sex hormone levels or some other 
sex-specific mechanism [7,8]. 
4. Conclusions 
We designed and validated a simple high-throughput glyco-
proteomic workflow for rat IgG Fc N-glycosylation analysis and 
demonstrated its applicability and performance on a cohort of male and 
female rats of different age exposed to chronic stress. The subclass- 
specific analysis exhibited satisfactory repeatability and reproduc-
ibility and revealed N-glycosylation diversity of rat IgG2a, IgG2b and 
IgG2c subclasses. 
The most prominent glycofeatures of animals exposed to chronic 
stress were galactosylation alterations. IgG2a exhibited an increased 
level of agalactosylated biantennary glycoforms and decreased levels of 
its monoantennary precursors, as well as monogalactosylated glyco-
forms. Together with a decline in IgG2c galactosylation, these effects 
indicated a pro-inflammatory state in young females. Conversely, old 
females showed an increased digalactosylation on IgG2b, exhibiting an 
increase in galactosylation and consequently the anti-inflammatory ac-
tivity of IgG. Even though old animals – especially females – were 
incapable of coping with stress, a reaction specific for pre- and post- 
menopausal age, their IgG glycan profile did not show an expected 
pro-inflammatory pattern. This suggested that animals in our study were 
still not old enough and might have been at least partially protected by 
sex hormones. The observed glycofeatures indicate an important effect 
of chronic stress on IgG N-glycosylation, which may trigger low-grade 
inflammation and highlight the sex-specific differences in rat IgG sub-
class glycosylation. 
Despite the overfrequent use of rats as animal models, their appli-
cation to human biology is not straightforward and remains challenging. 
Fig. 5. The quantitative analysis of GR (left) and CYP11B1 (right) immunoreactivity using integrated density value revealed significant sex-specific changes in the 
expression of both proteins upon chronic stress and aging. Significant differences are marked by lines, with exact p-values indicated below or above the lines. Black 
solid lines indicate significant differences in the expression of both between the animals of the same sex, while dashed-dotted lines indicate significant differences 
between sexes. Dashed lines represent significant age-specific differences in the expression of both proteins. Three-way factorial ANOVA was used for statistical 
comparison of different animal groups, with significant p-values for post hoc test shown. Abbreviations: GR = glucocorticoid receptor, OM-C = control group of old 
males, OM-S = stressed group of old males, OF-C = control group of old females, OF-S = stressed group of old females, YM-C = control group of young males, YM-S =
stressed group of young males, YF-C = control group of young females, YF-S = stressed group of young females. 
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The understudied role of glycosylation in the rodent immune response is 
gaining considerable interest, even though it is complicated by the in-
fluence of sex, age, and strain, with additional species-specific glycan 
structural and compositional diversity. This allows the conclusions to be 
drawn only very carefully to avoid unpredictable translational failures. 
We believe that our original insight into rat immunoglobulin 
glycosylation related to chronic stress will contribute to the growing 
field of glycoimmunology and glycan biomarker discovery. 
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J. Krǐstić, E.R. Nimmo, R. Kalla, H. Drummond, J. Štambuk, M.G. Dunlop, 
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